Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 trial evaluating the efficacy and safety of investigational treatments for moderate to severe hidradenitis suppurativa; the study is…
-
EMA approval · 2026-02-05EMA Authorised: Yuflyma (adalimumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Yuflyma (adalimumab) as a biosimilar of adalimumab for several inflammatory and autoimmune diseases, including rheumatoid art…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: MAIT Cells in Hidradenitis Suppurativa [NA]
A clinical trial update examining MAIT cells in hidradenitis suppurativa; the study is not yet recruiting and is sponsored by Hospices Civil…
-
EMA approval · 2026-02-04EMA Authorised: Imraldi (adalimumab) — Samsung Bioepis NL B.V.
EMA authorised Imraldi, a biosimilar adalimumab by Samsung Bioepis NL B.V., for multiple inflammatory diseases including ankylosing spondyli…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
A Phase 2 proof-of-concept study evaluating subcutaneous amlitelimab in adults with moderate-to-severe hidradenitis suppurativa has been ter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa [Phase 2]
Phase 2 study evaluating safety and pharmacokinetics of INF904 in adults with chronic spontaneous urticaria or hidradenitis suppurativa was …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa [Phase 2]
A Phase 2 clinical trial evaluating NAV-240 in adults with hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab [Phase 2, Phase 3]
A clinical trial update indicates a long-term study of spesolimab in hidradenitis suppurativa has been terminated (Phase 2/3).
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa [Phase 2]
Sanofi's Phase 2 trial of SAR442970 in adults with hidradenitis suppurativa has completed and results have been posted. The study evaluated …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation
This clinical trial update reports patient-reported changes in the burden of hidradenitis suppurativa after initiation of secukinumab, in a …
-
EMA approval · 2026-01-28EMA Authorised: Hukyndra (adalimumab) — Stada Arzneimittel AG
EMA authorised Hukyndra (adalimumab) from Stada Arzneimittel AG for multiple inflammatory diseases, including rheumatoid arthritis, psoriati…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients [NA]
A completed clinical trial investigating activation of a cutaneous inflammasome in the skin of patients with hidradenitis suppurativa.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012) [Phase 2]
Phase 2 clinical trial of Tulisokibart (MK-7240-012) for hidradenitis suppurativa is currently active but not recruiting, sponsored by Merck…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
The LANDSCAPE study, sponsored by Fondazione ISIDE, investigates demographics and treatment patterns of patients with immune-mediated inflam…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 3]
A Phase 3 study evaluating Povorcitinib (INCB054707) for moderate-to-severe hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Impact of Sex Hormones on Human Skin Immunity in Health and Hidradenitis Suppurativa (SIAP)
A clinical trial evaluating how sex hormones influence human skin immunity in healthy individuals and in hidradenitis suppurativa, sponsored…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]
A phase 2 trial comparing ATI-450 to placebo in moderate-to-severe hidradenitis suppurativa has completed and results have been posted.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. [Phase 1, Phase 2]
This clinical trial update reports on the evaluation of HB0043 for efficacy, safety, and tolerability in patients with Hidradenitis Suppurat…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Real-World Study on the Burden of Hidradenitis Suppurativa
This clinical trial update outlines a real-world observational study to assess the burden of hidradenitis suppurativa, sponsored by PeriPhar…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Pelashield™ PainGuard™ vs Restrata® in HS Surgery [NA]
This clinical trial compares Pelashield PainGuard with Restrata in the surgical management of hidradenitis suppurativa and is currently recr…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia
This clinical trial update reports on short-term treatment satisfaction for hidradenitis suppurativa patients initiated on secukinumab (Cose…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Periodontal Status and Disease Severity in Hidradenitis Suppurativa Patients
This clinical trial update reports on the periodontal status and disease severity in patients with hidradenitis suppurativa.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of topical roflumilast 0.3% foam for hidradenitis suppurativa, currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Managed Access Programs for AIN457, Secukinumab
Clinical trial update describing managed access programs for AIN457 (secukinumab) for hidradenitis suppurativa; the program status is AVAILA…
-
CLINICAL_TRIALS withdrawal · 2025-12-17Clinical Trial Update: Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients [NA]
A clinical trial evaluating the efficacy and tolerability of fractional ablative Erbium laser for axillary scarring in hidradenitis suppurat…